Literature DB >> 8096464

Design of (omega-N-(O-acyl)hydroxy amid) aminodicarboxylic acid pyrrolidides as potent inhibitors of proline-specific peptidases.

H U Demuth1, D Schlenzig, A Schierhorn, G Grosche, M P Chapot-Chartier, J C Gripon.   

Abstract

A novel class of competitive, acylating inhibitors for the proline-specific peptidases: dipeptidyl peptidase IV, dipeptidyl peptidase II and prolyl endopeptidase, has been developed. The inhibitor molecules combine the efficacy of aminoacyl pyrrolidides and the potential transacylating capability of diacyl hydroxyl amines. The N-terminal deblocked inhibitors are potent reversible inhibitors of porcine kidney dipeptidyl peptidase IV, human placenta dipeptidyl peptidase II exhibiting Ki values in the microM range. Boc-protected (omega-N-hydroxy acyl amid) aminodiacarboxylic acid pyrrolidides inhibit substrate hydrolysis by prolyl endopeptidases from different sources competitively reaching Ki values of 30 nM to 60 microM. Additionally, alpha-N-BOC-(omega-N-hydroxy acetyl) glutaminyl pyrrolidide modifies human placenta prolyl endopeptidase in a time-dependent reaction.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8096464     DOI: 10.1016/0014-5793(93)81649-k

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  4 in total

Review 1.  Pharmacogenetics in model systems: defining a common mechanism of action for mood stabilisers.

Authors:  Robin S B Williams
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2005-07       Impact factor: 5.067

2.  Cloning and characterization of dipeptidyl peptidase 10, a new member of an emerging subgroup of serine proteases.

Authors:  Shu Y Qi; Pierre J Riviere; Jerzy Trojnar; Jean-Louis Junien; Karen O Akinsanya
Journal:  Biochem J       Date:  2003-07-01       Impact factor: 3.857

3.  Loss of a prolyl oligopeptidase confers resistance to lithium by elevation of inositol (1,4,5) trisphosphate.

Authors:  R S Williams; M Eames; W J Ryves; J Viggars; A J Harwood
Journal:  EMBO J       Date:  1999-05-17       Impact factor: 11.598

4.  Dipeptidyl peptidase-IV inhibitory action of Calebin A: An in silico and in vitro analysis.

Authors:  Nehru Sai Suresh Chalichem; Srikanth Jupudi; Venkata Ramesh Yasam; Duraiswamy Basavan
Journal:  J Ayurveda Integr Med       Date:  2021-10-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.